ACSL4 and gastric cancer: Decreased CBS results in reduced methylation of the ACSL4 protein and facilitates polyubiquitination and degradation of ACSL4 via the ubiquitination-proteasome pathway, ultimately protecting gastric cancer against ferroptosis99.